Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles

Xiaoxi Huang, Tao Zhang, Xiaoxin Zou, Zhimin Tao, Teddy Asefa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.

Original languageEnglish
Pages (from-to)30226-30233
Number of pages8
JournalRSC Advances
Volume6
Issue number36
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Fenofibrate
Yeast
Dissolution
Silicon Dioxide
Carbon
Silica
Cells
Pharmaceutical Preparations
rhodamine B
Adsorption
Coatings
Gas adsorption
Molecules
Drug delivery
Prodrugs
Etching
Desorption
X ray photoelectron spectroscopy
Transmission electron microscopy
Nitrogen

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)

Cite this

Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles. / Huang, Xiaoxi; Zhang, Tao; Zou, Xiaoxin; Tao, Zhimin; Asefa, Teddy.

In: RSC Advances, Vol. 6, No. 36, 01.01.2016, p. 30226-30233.

Research output: Contribution to journalArticle

Huang, Xiaoxi ; Zhang, Tao ; Zou, Xiaoxin ; Tao, Zhimin ; Asefa, Teddy. / Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles. In: RSC Advances. 2016 ; Vol. 6, No. 36. pp. 30226-30233.
@article{dc02ba21a4a141378096ee862b2375dd,
title = "Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles",
abstract = "Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.",
author = "Xiaoxi Huang and Tao Zhang and Xiaoxin Zou and Zhimin Tao and Teddy Asefa",
year = "2016",
month = "1",
day = "1",
doi = "10.1039/c6ra00308g",
language = "English",
volume = "6",
pages = "30226--30233",
journal = "RSC Advances",
issn = "2046-2069",
publisher = "Royal Society of Chemistry",
number = "36",

}

TY - JOUR

T1 - Improving the dissolution of fenofibrate with yeast cell-derived hollow core/shell carbon microparticles

AU - Huang, Xiaoxi

AU - Zhang, Tao

AU - Zou, Xiaoxin

AU - Tao, Zhimin

AU - Asefa, Teddy

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.

AB - Hollow core/shell carbon microparticles, denoted HCSC600, are synthesized from yeast cells by coating the cells with silica shells, and then pyrolyzing the silica-protected yeast cells at 600°C, and finally etching the silica shells off of the carbonized products. The microparticles possess a yolk/shell structure with very large interior hollow spaces and interconnected porous structures-structural features that are generally useful for adsorption and release of drug molecules. The microparticles are characterized by various methods, including scanning electron microscopy, transmission electron microscopy, nitrogen gas adsorption/desorption and X-ray photoelectron spectroscopy. Their adsorption properties are evaluated by using rhodamine B (RhB) as a model drug and the poorly soluble drug fenofibrate (FFB), a prodrug of fenofibric acid, which is widely used to treat hypertriglyceridemia. Compared with the control material prepared from yeast cells without silica coating (named YCC600), the HCSC microparticles showed much higher adsorption capacity for both compounds, suggesting that the silica coating is important not only for controlling the morphology of the particles but also for giving them high surface area. Furthermore, it is found that the HCSC600 material loaded with FFB allows the drug molecules to be released faster and better than they are from the bulk drug. The results indicate that HCSC microparticles have great potential to serve as drug delivery vehicles, especially for poorly bioavailable drugs such as FFB, for biomedical applications.

UR - http://www.scopus.com/inward/record.url?scp=85022145047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022145047&partnerID=8YFLogxK

U2 - 10.1039/c6ra00308g

DO - 10.1039/c6ra00308g

M3 - Article

VL - 6

SP - 30226

EP - 30233

JO - RSC Advances

JF - RSC Advances

SN - 2046-2069

IS - 36

ER -